Upgrade to SI Premium - Free Trial

UBS Reiterates Sell Rating on Dillard's Inc. (DDS) Following Q1 Results

May 15, 2026 9:54 AM
UBS analyst Mauricio Serna reiterated a Sell rating and $465.00 price target on Dillard's Inc. (NYSE: DDS).The analyst commented, "DDS ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments